{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:56:49Z","timestamp":1785704209385,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.actbio.2026.06.037","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:07:46Z","timestamp":1781827666000},"page":"604-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fe3+-responsive aggregable gold nanoplatform enables siRNA-mediated chemoresistance reversal and combined photothermal\u2013temozolomide therapy for glioblastoma"],"prefix":"10.1016","volume":"219","author":[{"given":"Junhao","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meilin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qirui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuteng","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5414-9300","authenticated-orcid":false,"given":"Xuanrong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.actbio.2026.06.037_bib0001","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \"state of the science\" review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.actbio.2026.06.037_bib0002","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro-Oncol."},{"issue":"33","key":"10.1016\/j.actbio.2026.06.037_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202203958","article-title":"Brain co-delivery of temozolomide and cisplatin for combinatorial glioblastoma chemotherapy","volume":"34","author":"Zou","year":"2022","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.037_bib0004","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41467-019-14036-x","article-title":"Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways","volume":"11","author":"Meng","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.actbio.2026.06.037_bib0005","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/0008-5472.CAN-16-2983","article-title":"Temozolomide in the era of precision medicine","volume":"77","author":"Thomas","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.037_bib0006","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s13277-015-4240-2","article-title":"MGMT testing allows for personalised therapy in the temozolomide era","volume":"37","author":"Dullea","year":"2016","journal-title":"Tumor Biol."},{"issue":"2","key":"10.1016\/j.actbio.2026.06.037_bib0007","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.critrevonc.2015.05.013","article-title":"Limited advances in therapy of glioblastoma trigger re-consideration of research policy","volume":"96","author":"Frosina","year":"2015","journal-title":"Crit. Rev. Oncol. Hemat."},{"issue":"11","key":"10.1016\/j.actbio.2026.06.037_bib0008","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/gt.2010.88","article-title":"Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells","volume":"17","author":"Kato","year":"2010","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.actbio.2026.06.037_bib0009","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12935-021-02211-4","article-title":"An insertion variant of MGMT disrupts a STAT1 binding site and confers susceptibility to glioma","volume":"21","author":"Huang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.actbio.2026.06.037_bib0010","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202007166","article-title":"siRNA nanoparticle suppresses drug-resistant gene and prolongs survival in an orthotopic glioblastoma xenograft mouse model","volume":"31","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"4","key":"10.1016\/j.actbio.2026.06.037_bib0011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cgt.2016.4","article-title":"Precise and efficient siRNA design: a key point in competent gene silencing","volume":"23","author":"Fakhr","year":"2016","journal-title":"Cancer Gene. Ther."},{"issue":"13","key":"10.1016\/j.actbio.2026.06.037_bib0012","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.addr.2012.08.014","article-title":"RNAi-based nanomedicines for targeted personalized therapy, Adv","volume":"64","author":"Daka","year":"2012","journal-title":"Drug Delivery Rev."},{"issue":"4","key":"10.1016\/j.actbio.2026.06.037_bib0013","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11427-018-9438-y","article-title":"siRNA therapeutics: a clinical reality","volume":"63","author":"Saw","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.actbio.2026.06.037_bib0014","article-title":"siRNA versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.actbio.2026.06.037_bib0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd4685","article-title":"Clinical experiences with systemically administered siRNA-based therapeutics in cancer","volume":"14","author":"Zuckerman","year":"2015","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"5","key":"10.1016\/j.actbio.2026.06.037_bib0016","first-page":"497","article-title":"Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA","volume":"14","author":"Raja","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.actbio.2026.06.037_bib0017","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrg3978","article-title":"Knocking down disease: a progress report on siRNA therapeutics","volume":"16","author":"Wittrup","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.actbio.2026.06.037_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104753","article-title":"Gold nanoparticles in glioma theranostics","volume":"156","author":"Norouzi","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.actbio.2026.06.037_bib0019","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1039\/C1NR11188D","article-title":"Gold nanoparticles: preparation, properties, and applications in bionanotechnology","volume":"4","author":"Yeh","year":"2012","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.actbio.2026.06.037_bib0020","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1039\/C0CS00018C","article-title":"Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies","volume":"40","author":"Khlebtsov","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"9","key":"10.1016\/j.actbio.2026.06.037_bib0021","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and photothermal therapies: synergy opportunities for nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.actbio.2026.06.037_bib0022","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1039\/C8TB02484G","article-title":"Current status and future perspectives of gold nanoparticle vectors for siRNA delivery","volume":"7","author":"Artiga","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"9","key":"10.1016\/j.actbio.2026.06.037_bib0023","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1039\/C9MH00482C","article-title":"Switchable nanoparticle for programmed gene-chem delivery with enhanced neuronal recovery and CT imaging for neurodegenerative disease treatment","volume":"6","author":"Liu","year":"2019","journal-title":"Mater. Horiz."},{"issue":"5","key":"10.1016\/j.actbio.2026.06.037_bib0024","article-title":"Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles","volume":"9","author":"Selby","year":"2017","journal-title":"Wiley Interdiscip. Rev.:Nanomed. Nanobiotechnol."},{"issue":"43","key":"10.1016\/j.actbio.2026.06.037_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201903860","article-title":"Furin-controlled Fe3O4 nanoparticle aggregation and 19F signal \"Turn-On\" for precise MR imaging of tumors","volume":"29","author":"Ding","year":"2019","journal-title":"Adv. Funct. Mater."},{"issue":"5","key":"10.1016\/j.actbio.2026.06.037_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202209749","article-title":"Transformable nanotheranostics capable of sensoring nucleic acid drugs\u2019 spatiotemporal behaviors","volume":"33","author":"Shen","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.actbio.2026.06.037_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118399","article-title":"Gold nanoparticle-mediated photothermal therapy: Expanding the frontiers of cancer treatment and theragnostics","volume":"190","author":"Amaral","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"33","key":"10.1016\/j.actbio.2026.06.037_bib0028","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1039\/D4TB00403E","article-title":"Aggregable gold nanoparticles for cancer photothermal therapy","volume":"12","author":"Wu","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"5","key":"10.1016\/j.actbio.2026.06.037_bib0029","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1021\/acsnano.9b01591","article-title":"Dopamine-mediated assembly of citrate-capped plasmonic nanoparticles into stable core\u2013shell nanoworms for intracellular applications","volume":"13","author":"Choi","year":"2019","journal-title":"ACS Nano"},{"issue":"33","key":"10.1016\/j.actbio.2026.06.037_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202420630","article-title":"Intranasal and intravenous sequential administration of survivin peptide-CpG nanovaccines elicits potent immunity toward glioblastoma","volume":"37","author":"Shi","year":"2025","journal-title":"Adv. Mater."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126003971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126003971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:29:45Z","timestamp":1785702585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126003971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S1742706126003971"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.06.037","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fe3+-responsive aggregable gold nanoplatform enables siRNA-mediated chemoresistance reversal and combined photothermal\u2013temozolomide therapy for glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}